Literature DB >> 15483673

Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells.

I Ringshausen1, T Dechow, F Schneller, K Weick, M Oelsner, C Peschel, T Decker.   

Abstract

In the present work we investigated the role and biological significance of mitogen activated protein kinases (MAPK) in B-cell chronic lymphocytic leukaemia (B-CLL). The MAPK p38 was constitutively activated in B-CLL, but not in normal peripheral B cells. In addition, we demonstrated that the upstream kinases of p38, MKK3/6 were also constitutively activated in B-CLL cells. Furthermore, we determined by EMSA that the p38 MAP kinase pathway was not linked to the constitutive high expression of NF-kappaB, a critical survival factor of B-CLL cells. Recently, it has been shown that serum levels of angiogenic factors like VEGF, bFGF and MMP-9 are elevated in the serum of CLL patients and correlate with an unfavorable prognosis. We showed that the constitutive expression of MMP-9 was dependent on p38-activity and inhibition of p38 strongly downregulated MMP-9 expression. Coculture of B-CLL cells and stromal cells can protect spontaneous apoptosis of leukemic B cells. To determine the role of permanently activated p38 and MMP-9 expression, we cocultured B-CLL cells with bone marrow stromal cells. Survival of B-CLL cells on stroma was severely impaired when p38 was inhibited. Furthermore, blockade of MMP-9 activity also antagonized the antiapoptotic effect of stromal cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15483673     DOI: 10.1038/sj.leu.2403544

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  24 in total

Review 1.  Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemia.

Authors:  Kumudha Balakrishnan; Varsha Gandhi
Journal:  Expert Opin Investig Drugs       Date:  2012-03-09       Impact factor: 6.206

2.  Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment.

Authors:  Heath B Acuff; Kathy J Carter; Barbara Fingleton; D Lee Gorden; Lynn M Matrisian
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

3.  Six1 promotes colorectal cancer growth and metastasis by stimulating angiogenesis and recruiting tumor-associated macrophages.

Authors:  Hanwen Xu; Yu Zhang; Maria M Peña; Lucia Pirisi; Kim E Creek
Journal:  Carcinogenesis       Date:  2017-03-01       Impact factor: 4.944

4.  T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.

Authors:  Rajendra N Damle; Sonal Temburni; Taraneh Banapour; Santanu Paul; Patricia K A Mongini; Steven L Allen; Jonathan E Kolitz; Kanti R Rai; Nicholas Chiorazzi
Journal:  Blood       Date:  2012-08-08       Impact factor: 22.113

5.  Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2.

Authors:  Angela Schulz; Grischa Toedt; Thorsten Zenz; Stephan Stilgenbauer; Peter Lichter; Martina Seiffert
Journal:  Haematologica       Date:  2010-12-06       Impact factor: 9.941

6.  Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia.

Authors:  Charalampos Pontikoglou; Maria-Christina Kastrinaki; Mirjam Klaus; Christina Kalpadakis; Pavlos Katonis; Kalliopi Alpantaki; Gerassimos A Pangalis; Helen A Papadaki
Journal:  Stem Cells Dev       Date:  2013-02-01       Impact factor: 3.272

7.  miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways.

Authors:  Lingyin Ge; David M Habiel; Phil M Hansbro; Richard Y Kim; Sina A Gharib; Jeffery D Edelman; Melanie Königshoff; Tanyalak Parimon; Rena Brauer; Ying Huang; Jenieke Allen; Dianhua Jiang; Adrianne A Kurkciyan; Takako Mizuno; Barry R Stripp; Paul W Noble; Cory M Hogaboam; Peter Chen
Journal:  JCI Insight       Date:  2016-12-08

Review 8.  Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications.

Authors:  Yair Herishanu; Ben-Zion Katz; Andrew Lipsky; Adrian Wiestner
Journal:  Hematol Oncol Clin North Am       Date:  2013-04       Impact factor: 3.722

9.  Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL).

Authors:  Katy Hanlon; Claudius E Rudin; Lorna W Harries
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

Review 10.  Non-classical p38 map kinase functions: cell cycle checkpoints and survival.

Authors:  Tina M Thornton; Mercedes Rincon
Journal:  Int J Biol Sci       Date:  2008-12-19       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.